573 related articles for article (PubMed ID: 8970881)
21. Dynamic contrast-enhanced magnetic resonance imaging in a model of splenic metastasis.
Runge VM; Williams NM
Invest Radiol; 1998 Jan; 33(1):45-50. PubMed ID: 9438509
[TBL] [Abstract][Full Text] [Related]
22. Detection of liver metastases: comparison of gadobenate dimeglumine-enhanced and ferumoxides-enhanced MR imaging examinations.
del Frate C; Bazzocchi M; Mortele KJ; Zuiani C; Londero V; Como G; Zanardi R; Ros PR
Radiology; 2002 Dec; 225(3):766-72. PubMed ID: 12461259
[TBL] [Abstract][Full Text] [Related]
23. The use of gadolinium-BOPTA on magnetic resonance imaging in brain infection.
Runge VM; Wells JW; Williams NM; Timoney JF; Lee C
Invest Radiol; 1996 May; 31(5):294-9. PubMed ID: 8724129
[TBL] [Abstract][Full Text] [Related]
24. [Evaluation of Gd-BOPTA and Gd-DTPA in contrast-enhanced MR imaging of the liver].
Zhang HM; Ouyang H; Zhou CW
Zhonghua Zhong Liu Za Zhi; 2006 Feb; 28(2):111-5. PubMed ID: 16750014
[TBL] [Abstract][Full Text] [Related]
25. Clinical late phase II trials of MultiHance (Gd-BOPTA) for the magnetic resonance imaging of liver tumors in Japan.
Kuwatsuru R; Kadoya M; Ohtomo K; Tanimoto A; Hirohashi S; Murakami T; Tanaka Y; Yoshikawa K; Katayama H
J Comput Assist Tomogr; 1999 Nov; 23 Suppl 1():S65-74. PubMed ID: 10608400
[TBL] [Abstract][Full Text] [Related]
26. Detectability of early brain meningitis with magnetic resonance imaging.
Runge VM; Wells JW; Williams NM; Lee C; Timoney JF; Young AB
Invest Radiol; 1995 Aug; 30(8):484-95. PubMed ID: 8557515
[TBL] [Abstract][Full Text] [Related]
27. The efficacy of gadobenate dimeglumine (Gd-BOPTA) at 3 Tesla in brain magnetic resonance imaging: comparison to 1.5 Tesla and a standard gadolinium chelate using a rat brain tumor model.
Runge VM; Biswas J; Wintersperger BJ; Baumann SS; Jackson CB; Herborn CU; Patel T
Invest Radiol; 2006 Mar; 41(3):244-8. PubMed ID: 16481906
[TBL] [Abstract][Full Text] [Related]
28. MR imaging of the liver with Gd-BOPTA: quantitative analysis of T1-weighted images at two different doses.
Schima W; Saini S; Petersein J; Weissleder R; Harisinghani M; Mayo-Smith W; Hahn PF
J Magn Reson Imaging; 1999 Jul; 10(1):80-3. PubMed ID: 10398981
[TBL] [Abstract][Full Text] [Related]
29. High-dose applications of gadolinium chelates in magnetic resonance imaging.
Runge VM; Kirsch JE; Thomas GS
Magn Reson Med; 1991 Dec; 22(2):358-63. PubMed ID: 1812371
[TBL] [Abstract][Full Text] [Related]
30. Assessment of acute myocardial infarction in man with magnetic resonance imaging and the use of a new paramagnetic contrast agent gadolinium-BOPTA.
Holman ER; van Rossum AC; Doesburg T; van der Wall EE; de Roos A; Visser CA
Magn Reson Imaging; 1996; 14(1):21-9. PubMed ID: 8656987
[TBL] [Abstract][Full Text] [Related]
31. Contrast-enhanced magnetic resonance cholangiography with Gd-BOPTA and Gd-EOB-DTPA in healthy subjects.
Dahlström N; Persson A; Albiin N; Smedby O; Brismar TB
Acta Radiol; 2007 May; 48(4):362-8. PubMed ID: 17453513
[TBL] [Abstract][Full Text] [Related]
32. Delayed Gadolinium-enhanced MR Imaging of Cartilage: A Comparative Analysis of Different Gadolinium-based Contrast Agents in an ex Vivo Porcine Model.
Kang Y; Choi JY; Yoo HJ; Hong SH; Kang HS
Radiology; 2017 Mar; 282(3):734-742. PubMed ID: 27649101
[TBL] [Abstract][Full Text] [Related]
33. Focal malignant hepatic lesions: MR imaging enhanced with gadolinium benzyloxypropionictetra-acetate (BOPTA)--preliminary results of phase II clinical application.
Caudana R; Morana G; Pirovano GP; Nicoli N; Portuese A; Spinazzi A; Di Rito R; Pistolesi GF
Radiology; 1996 May; 199(2):513-20. PubMed ID: 8668804
[TBL] [Abstract][Full Text] [Related]
34. Comparison of gadobenate dimeglumine (Gd-BOPTA) with gadopentetate dimeglumine (Gd-DTPA) for enhanced MR imaging of brain and spine tumours in children.
Colosimo C; Demaerel P; Tortori-Donati P; Christophe C; Van Buchem M; Högström B; Pirovano G; Shen N; Kirchin MA; Spinazzi A
Pediatr Radiol; 2005 May; 35(5):501-10. PubMed ID: 15678342
[TBL] [Abstract][Full Text] [Related]
35. Contrast-enhanced MR imaging of the liver: comparison between Gd-BOPTA and Mangafodipir.
Schima W; Petersein J; Hahn PF; Harisinghani M; Halpern E; Saini S
J Magn Reson Imaging; 1997; 7(1):130-5. PubMed ID: 9039603
[TBL] [Abstract][Full Text] [Related]
36. [A comparative study between Gd-BOPTA, a biliary excretion contrast medium, and Gd-DTPA in the magnetic resonance imaging of the rat liver].
Patrizio G; Pavone P; Cardone G; Pietroletti R; Passariello R; Tettamanti E; Musu C; Felder E
Radiol Med; 1990 May; 79(5):458-62. PubMed ID: 2359853
[TBL] [Abstract][Full Text] [Related]
37. Magnetic resonance imaging of an experimental model of intracranial metastatic disease. A study of lesion detectability.
Runge VM; Wells JW; Williams NM
Invest Radiol; 1994 Dec; 29(12):1050-6. PubMed ID: 7721546
[TBL] [Abstract][Full Text] [Related]
38. Delayed MR imaging of hepatocellular carcinoma enhanced by gadobenate dimeglumine (Gd-BOPTA).
Manfredi R; Maresca G; Baron RL; Cotroneo AR; De Gaetano AM; De Franco A; Pirovano G; Spinazzi A; Marano P
J Magn Reson Imaging; 1999 May; 9(5):704-10. PubMed ID: 10331767
[TBL] [Abstract][Full Text] [Related]
39. [Brain magnetic resonance with magnetization transfer in multiple sclerosis. Lesion hyperintensity before and after intravenous gadolinium administration].
Renzetti P; Parodi RC; Losacco C; Rosso E; Arcuri T; Sardanelli F
Radiol Med; 1999 Sep; 98(3):138-43. PubMed ID: 10575442
[TBL] [Abstract][Full Text] [Related]
40. Kinetics of gadobenate dimeglumine in isolated perfused rat liver: MR imaging evaluation.
Pastor CM; Planchamp C; Pochon S; Lorusso V; Montet X; Mayer J; Terrier F; Vallee JP
Radiology; 2003 Oct; 229(1):119-25. PubMed ID: 12944603
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
